Phase 2 Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with a specific type of bladder cancer (called high-grade transitional cell carcinoma) that has not grown into the bladder muscle, confirmed by a tissue sample
- Your bladder cancer has not responded to BCG treatment (a common bladder cancer therapy), and this has been confirmed by tissue testing
- After surgical removal of tumors (a procedure called TURBT), there is no remaining removable disease — though some surface-level cancer cells in the lining may still be present
- You are either unwilling to have your bladder surgically removed, or your doctor has determined that surgery is not suitable for you
- Your general health and activity level fall within an acceptable range (confirm with trial site)
- Your doctor expects you to live for at least 2 more years
- Your major organs (such as kidneys, liver, and heart) are functioning well enough to participate
- You are willing to give written consent and agree to follow all trial procedures and check-ups
Who may not be able to join:
- You have previously received certain immune-boosting therapies involving IL-2 or IL-15 (specific drug types — confirm with trial site)
- You received significant pelvic radiation therapy within the past 2 years
- You received any systemic (whole-body) treatment for your bladder cancer within the past 4 weeks
- You received any treatment directly into the bladder (intravesical therapy) within the past 4 weeks
- You had bladder surgery (such as TURBT) within the past 2 weeks
- You have a known allergy to the trial drug or similar types of treatments, or to BCG (confirm with trial site)
- You have been taking immune-suppressing medications at significant doses within the past 4 weeks (some low-dose exceptions may apply — confirm with trial site)
- You have previously had an organ transplant or bone marrow/stem cell transplant from another person
- You received a live virus vaccine within the past 4 weeks
- You previously had a severe or treatment-stopping immune-related side effect from an immunotherapy drug (some exceptions may apply — confirm with trial site)
- You have unresolved serious side effects from previous cancer treatments that have not sufficiently improved
- You have a history of bladder cancer that has grown into the muscle or spread to other parts of the body
- You have had tumors in your upper urinary tract (such as the kidneys or ureters) or in the urethral area near the prostate
- You have a known condition where urine flows backward from the bladder to the kidneys, or there is evidence of a hole in your bladder
- You currently have an active urinary tract infection
- You had to stop BCG treatment in the past due to serious reactions such as blood poisoning or serious infection
- You have complications from bladder surgery that would prevent treatment being placed directly into the bladder
- You produce an unusually large amount of urine each day (more than 4,000 mL in 24 hours)
- You have been diagnosed with another cancer within the past 2 years that is still active or required treatment
- You have an active autoimmune disease that requires immune-suppressing medication
- You have a history of serious lung damage or lung toxicity
- You have had active tuberculosis (TB) in the lungs within the past year, or a past TB infection that was not fully treated
- You have uncontrolled fluid build-up around your lungs, heart, or abdomen that requires frequent draining
- You have a significant history of serious heart disease
- You had major surgery within the past 4 weeks
- You have had a serious infection within the past 4 weeks
- You have ever had confirmed active Hepatitis B, Hepatitis C, HIV, or active tuberculosis
- You are currently pregnant or breastfeeding
- You have a known or suspected substance misuse problem (certain exceptions for medically prescribed medications may apply — confirm with trial site)
- Your doctor determines there is any other reason you would not be suitable for this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-18101882657
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
MTD; RP2D; Safety and tolerability; Complete Response; Disease-Free Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.